A heart attack is far from an isolated, acute event. The consequences of an attack can cause serious and lasting damage, ...
Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people ...
Participants exposed critical gaps in the diagnosis, treatment, and coordination of care for patients with heart failure with preserved ejection fraction and charted a path forward.
The Healthy @Reader's Digest on MSN
New study says if you had this in childhood, your heart disease risk could be up to 45% higher
Research in the International Journal of Cardiology shines light on yet another reason to attend to dental health, even at a ...
Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, ...
Heart failure’s unpredictable trajectory often delays palliative referral; early integration and proactive follow-up can ...
Substantial variations in referrals for advanced heart failure therapies are apparent across the UK and Ireland, with no ...
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally, sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results